Affiliation:
1. National Neuroscience Institute, Singapore
Abstract
Introduction: The aim of this study was to determine the clinical characteristics and patients’ perception of hemifacial spasm (HFS) in Singapore.
Materials and Methods: A clinical survey of 137 consecutive patients with HFS seen in our Botulinum Toxin Clinic over a 15-month period was undertaken.
Results: Forty-six men and 91 women were interviewed. Their mean age at onset of HFS was 48 years. The median disease duration was 60 months (range, 2 to 360 months). Left-sided spasm was common in 51.8% of patients, and the orbicularis oculi was the first muscle to be affected in 86.1% of them. The majority (65%) had the spasm aggravated by stress and anxiety. In fact, 32 patients perceived stress and anxiety as a possible aetiology of HFS. Stroke was a main concern in 17 patients and 7 patients thought the spasm was a sign of demonic possession or a bad omen. The spasm embarrassed 75.2% of the patients, rendered 65% of them depressed, affected the vision in 60.6% of them and compromised their work performance in 35.8%. Overall, treatment was delayed by a median interval of 6 months from onset of symptoms (range, 0 to 132). More than half (53.3%) tried traditional therapies (acupuncture or herbal medicine), while only 48.2% had botulinum toxin as the initial treatment. All patients eventually received botulinum toxin injections and more than 90% showed improvement at 1 month posttreatment.
Conclusions: The clinical characteristics and patients’ perception of HFS in Singapore were presented. HFS affects patients both psychosocially and functionally. Effective treatment with botulinum toxin exists and should be provided early to the patients.
Publisher
Academy of Medicine, Singapore
Reference24 articles.
1. Tan EK, Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord 1999;14:345-9.
2. Auger RG, Whisnant JP. Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 1990;47:1233-4.
3. Tan AK. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore. Singapore Med J 1998;39:403-5.
4. Ho SL, Cheng PW, Wong WC, Chan FL, Lo SK, Li LS, et al. A casecontrolled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology 1999;53:2132-9.
5. Lorentz IT. Treatment of hemifacial spasm with botulinum toxin. J Clin Neurosci 1995;2:132-5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献